CUG-252

N/A

Report date: 2025/03/11 11:44:29

Base Information

Drug NameCUG-252
Drug Alias NameCUG-252
ClassificationBiologics > Protein drugs
Mechanisms of ActionRegulatory T-lymphocytes stimulantsInterleukin-2 replacements
TargetsInterleukin-2
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCugene Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie IncCugene Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A